Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Autism App Adapts Facial Analysis Software

The Autism and Beyond app assesses a child’s emotional state while viewing various stimuli. The dots are landmarks automatically placed on a video of the child by the software. (courtesy, Autism and Beyond)

31 December 2015. A research team at Duke University is using facial analysis software routines developed for the U.S. Navy . . . → Read More: Autism App Adapts Facial Analysis Software

Trial Underway Testing Preterm Respiratory Treatment

(Pacific Northwest National Lab)

30 December 2015. A clinical trial testing new treatment methods for a common respiratory disorder faced by preterm babies began enrolling patients. The trial is testing an aerosol-delivered surfactant, a wetting agent applied to the lungs of babies born prematurely without natural surfactants to keep open air sacs in . . . → Read More: Trial Underway Testing Preterm Respiratory Treatment

Cancer Genome Data Visualization Tool Developed

Jinghui Zhang (St. Jude Children’s Research Hospital)

29 December 2015. A bioinformatics team at St. Jude Children’s Research Hospital created a Web-based system that illustrates genetic mutations behind pediatric cancers. The software and database in ProteinPaint, as the system is called, are described in a letter in today’s issue of the journal Nature . . . → Read More: Cancer Genome Data Visualization Tool Developed

€50,000 Challenge Seeks New Gas Technologies

(Courtesy, Air Liquire)

28 December 2015. A challenge competition from industrial gas developer Air Liquide asks researchers to devise new solutions for three sustainable applications of gas molecules. Each of the three challenges awards a cash prize of €50,000 ($US 55,000), and an opportunity to earn another €500,000 in funding to develop the . . . → Read More: €50,000 Challenge Seeks New Gas Technologies

Human Cornea Cells Derived from Stem Cells

(U.S. Southern Command)

28 December 2015. A biotechnology company designed a process for generating human cornea cells from embryonic stem cells, without a donated cornea, the current replacement therapy. The team from Ocata Therapeutics Inc. led by Robert Lanza, the company’s chief scientist, published its proof-of-concept findings last week in the journal . . . → Read More: Human Cornea Cells Derived from Stem Cells

Christmas 2015

25 December 2015. Today is the Christmas holiday in much of the world, and Science & Enterprise will be off today as well. We’ll continue our regular posts on Monday, 28 December. (Photo: A. Kotok)

* * *

Trial Shows Vaccine Protects Against Stem Cell Complications

(Stux, Pixabay)

24 December 2015. An early-stage clinical trial indicates a vaccine protects against complications from stem cell transplants used to treat blood-related cancers. Results of the trial conducted by City of Hope medical center in Duarte, California that developed the vaccine appear online in the journal The Lancet Haematology (paid subscription required), . . . → Read More: Trial Shows Vaccine Protects Against Stem Cell Complications

Dust Stop Concentrate

– Sponsored content-

Dust Stop being applied (Cypher Environmental)

23 December 2015. Dust Stop Liquid Concentrate is a 100% environmentally friendly solution that is very effective for long term dust and erosion control for tailings piles consisting of any material. After application of the emulsion to the tailings, the water evaporates . . . → Read More: Dust Stop Concentrate

Bioactive Glass Reduces Decay in Tooth Cavity Fillings

Bioactive glass (Oregon State University)

23 December 2015. An engineering group at Oregon State University adapted a type of glass material that in lab models slows the decay in teeth with composite cavity fillings. The team led by materials engineering professor Jamie Kruzic published its findings in the January 2016 issue of the . . . → Read More: Bioactive Glass Reduces Decay in Tooth Cavity Fillings

Start-Up Licenses Founder’s Research for Resistant Bacteria

(Centers for Disease Control and Prevention)

22 December 2015. A biotechnology company spun-off from University of California in San Diego is licensing technology from the university to develop treatments for bacterial infections now becoming resistant to conventional antibiotics. Financial terms of the licensing agreement between UC-San Diego and Forge Therapeutics were not disclosed.

. . . → Read More: Start-Up Licenses Founder’s Research for Resistant Bacteria